APP and Alzheimer disease: Moreover, it is supported by the fact that C. elegans APP related protein (APL-1) does not contain an Aβ sequence and available AD models rely on transgenic expression of the human Aβ toxic peptide [3, 14], rather than on increased pro-amyloidogenic processing of APP.